Breast Carcinoma Flashcards
1
Q
Definition?
A
Malignancy of epithelial cells originating in breast and nodal basins.
Can be confined to the basement membrane (carcinoma in-situ)
Can be squamous or glandular (adenocarcinoma)
2
Q
Risk factors?
A
- Old age
- Female
- Ethnicity
- Family history
- Genetic mutations
- Oestrogen/progestogen exposure
- Alcohol
- Radiation
- High SE class
- Benign breast disease
- Increased breast density
3
Q
Differentials?
A
- Benign breast disease
- Fibrocystic changes-symmetrical, pain worse in second half of cycle, younger
- Fibroadenoma-smooth, well-circumscribed mobile mass-worse in high oestrogen levels
- Mastitis-lactating or breastfeeding-inflamed and signs of infection
4
Q
Epidemiology?
A
Age: Older
Sex: Women
Ethnicity: White
Prevalence:
5
Q
Aetiology?
A
• Genetics-BRCA1 and 2 mutations-5-10% cancers
Exogenous sex hormone exposure
6
Q
Clinical Presentation?
A
- Asymmetrical breasts
- Mass-non-tender/painless , poorly defined margins in upper outer quadrant
- Retractions/dimpling
- Peau d’orange
- Blood-white nipple discharge
- Axillary lymphadenopathy
7
Q
Pathophysiology?
A
- In the menstrual cycle, there are increases mitoses of myoepithelial cell/glandular tissue in the alveoli lining, which increases teh risk of mutations
- Mutations in TSG’s are AD-can increase risk of familial cancer-lack of homologous recombination of double-stranded breaks
- Mutations in EBB2 increases HER2-gorwth factor of cell division
- Rapid and uncontrolled cancers
- DCIS-ductal carcinoma in situ-hasn’t crossed basement membrane
- Paget’s disease/inflammatory carcinoma-cells break off and migrate via lactiferous ducts onto the skin and settle between squamous cells and causes an inflammatory response-exudate dries on skin as crusts
- LCIS-local
- Lobular carcinoma-alveoli and lobules
- Infiltrates into pec muscles-immobile
- Fibrosis of ligaments-retraction
- PDO-lymph build up in interstitial spaces stretching skin on top
8
Q
Investigations-first line?
A
- Breast examination and history
- Asymmetry, masses, nipple deviation/retraction/scaling, scars, axillary lymph nodes, nipple discharge, skin changes, peau d’orange
9
Q
Investigations-second line?
A
- Mammogram-
- screening for over40’s/suspected pts
- High specificity and sensitivity
- Assessed by 2 readers
10
Q
Investigations-third line?
A
MRI
US
Biopsy
genetic/receptor testing
11
Q
MRI?
A
- High sensitivity but medium specificity
* For known mutation, first-degree relative with it or have lifetime risk >20%, radiation or TP53 mutation
12
Q
US?
A
- Eliminates fibrocystic disease, other masses and lymph nodes
- Assess response in neoadjuvant chemo
13
Q
Biopsy?
A
- Core-specific and can assess receptor status
- FNA-rapid, high sensitivity an specificity if done by experienced clinician
- Invasive ductal
- Invasive lobular
- Medullary
- Mucinous
- metaplastic
14
Q
Genetic/hormone testing?
A
- OR and PR using immunohistochemistry assay
- HER2 testing -positive means can be given Herceptin
- ER testing-positive means can be given oestrogen-antagonising therapy